Vistin Pharma ASA (DE:VP4) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Vistin Pharma ASA, a Norwegian pharmaceutical company, has announced it will release its second quarter and year-to-date results for 2024 on August 23rd and will also host a conference call with a Q&A session in English on the same day. The call will be accessible via webcast and telephone conference. Vistin Pharma specializes in the production of Metformin Hydrochloride and is a key supplier in Europe.
For further insights into DE:VP4 stock, check out TipRanks’ Stock Analysis page.